{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:15:32Z","timestamp":1789748132423,"version":"4.0.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,10,15]]},"DOI":"10.1086\/421960","type":"journal-article","created":{"date-parts":[[2004,10,4]],"date-time":"2004-10-04T14:49:35Z","timestamp":1096901375000},"page":"S218-S223","source":"Crossref","is-referenced-by-count":37,"title":["Design of Efficacy Trials of Cytokines in Combination with Antifungal Drugs"],"prefix":"10.1093","volume":"39","author":[{"given":"Bart Jan","family":"Kullberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid M. L. Oude","family":"Lashof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2004,10,15]]},"reference":[{"key":"key\n\t\t\t\t20171014003133_ref1","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199903113401004","article-title":"Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia","volume":"340","author":"Walsh","year":"1999","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014003133_ref2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014003133_ref3","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014003133_ref4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0002-9343(98)00030-8","article-title":"Predictors of adverse outcome in cancer patients with candidemia","volume":"104","author":"Anaissie","year":"1998","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20171014003133_ref5","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1086\/374850","article-title":"A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects","volume":"36","author":"Rex","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014003133_ref6","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/clinids\/23.3.608","article-title":"Therapeutic outcome in invasive aspergillosis","volume":"23","author":"Denning","year":"1996","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014003133_ref7","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.4049\/jimmunol.163.3.1498","article-title":"Increased susceptibility of TNF-\u03b1\/LT\u03b1 double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans","volume":"163","author":"Netea","year":"1999","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20171014003133_ref8","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1086\/314493","article-title":"Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis","volume":"178","author":"Cenci","year":"1998","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014003133_ref9","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1086\/318077","article-title":"Elevated serum concentrations of interleukin-10 in nonneutropenic patients with invasive aspergillosis","volume":"183","author":"Roilides","year":"2001","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014003133_ref10","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1182\/blood-2002-01-0265","article-title":"Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies","volume":"100","author":"Hebart","year":"2002","journal-title":"Blood"},{"key":"key\n\t\t\t\t20171014003133_ref11","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0923-2494(98)80771-2","article-title":"Cytokines as therapy for opportunistic fungal infections","volume":"149","author":"Kullberg","year":"1998","journal-title":"Res Immunol"},{"key":"key\n\t\t\t\t20171014003133_ref12","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/infdis\/168.2.436","article-title":"Recombinant interferon-\u03b3 enhances resistance to acute disseminated Candida albicans infection in mice","volume":"168","author":"Kullberg","year":"1993","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014003133_ref13","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/IAI.70.6.3284-3286.2002","article-title":"Role of interleukin-18 in host defense against disseminated Candida albicans infection","volume":"70","author":"Stuyt","year":"2002","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20171014003133_ref14","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/infdis\/169.6.1325","article-title":"Cure of murine candidiasis by recombinant soluble interleukin-4 receptor","volume":"169","author":"Puccetti","year":"1994","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014003133_ref15","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.4049\/jimmunol.152.7.3514","article-title":"Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans","volume":"152","author":"Romani","year":"1994","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20171014003133_ref16","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0092-8674(00)80172-5","article-title":"The dorsoventral regulatory gene cassette spatzle\/Toll\/cactus controls the potent antifungal response in Drosophila adults","volume":"86","author":"Lemaitre","year":"1996","journal-title":"Cell"},{"key":"key\n\t\t\t\t20171014003133_ref17","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","article-title":"Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene","volume":"282","author":"Poltorak","year":"1998","journal-title":"Science"},{"key":"key\n\t\t\t\t20171014003133_ref18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1074-7613(00)80119-3","article-title":"Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components","volume":"11","author":"Takeuchi","year":"1999","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20171014003133_ref19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0952-7915(01)00304-1","article-title":"Toll-like receptors: key mediators of microbe detection","volume":"14","author":"Underhill","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"key\n\t\t\t\t20171014003133_ref20","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/44605","article-title":"The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens","volume":"401","author":"Underhill","year":"1999","journal-title":"Nature"},{"key":"key\n\t\t\t\t20171014003133_ref21","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.4049\/jimmunol.166.7.4620","article-title":"Toll-like receptor 4 mediates intracellular signaling without TNF-\u03b1 release in response to Cryptococcus neoformans polysaccharide capsule","volume":"166","author":"Shoham","year":"2001","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20171014003133_ref22","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1086\/340511","article-title":"The role of Toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis","volume":"185","author":"Netea","year":"2002","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014003133_ref23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/76048","article-title":"TLR4 mutations are associated with endotoxin hyporesponsiveness in humans","volume":"25","author":"Arbour","year":"2000","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20171014003133_ref24","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.4049\/jimmunol.172.6.3712","article-title":"Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells","volume":"172","author":"Netea","year":"2004","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20171014003133_ref25","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1086\/376456","article-title":"Aspergillus fumigatus evades immune recognition during germination through loss of Toll-like receptor-4-mediated signal transduction","volume":"188","author":"Netea","year":"2003","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014003133_ref26","first-page":"479","article-title":"A double-blind, randomized, placebo-controlled phase II study of filgrastim (recombinant granulocyte colony-stimulating factor) in combination with fluconazole for treatment of invasive candidiasis and candidemia in nonneutropenic patients [abstract J-100]","volume-title":"Program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego)","author":"Kullberg","year":"1998"},{"key":"key\n\t\t\t\t20171014003133_ref27","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1086\/420829","article-title":"Recombinant interferon-\u03b3 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis","volume":"189","author":"Pappas","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014003133_ref28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/320876","article-title":"Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses","volume":"33","author":"Rex","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014003133_ref29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv Enzyme Regul"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/39\/Supplement_4\/S218\/20905912\/39-Supplement_4-S218.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T12:28:14Z","timestamp":1682771294000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/39\/Supplement_4\/S218\/321613\/Design-of-Efficacy-Trials-of-Cytokines-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,15]]},"references-count":29,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2004,10,15]]},"published-print":{"date-parts":[[2004,10,15]]}},"URL":"https:\/\/doi.org\/10.1086\/421960","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,10,15]]},"published":{"date-parts":[[2004,10,15]]}}}